Journal of Cardiac Failure
Volume 5, Issue 4 , Pages 357-382, December 1999

HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approaches☆

  • Heart Failure Society Of America

      Affiliations

    • Corresponding Author InformationSingle reprints are available by faxing a request to 612-624-2174 or writing to HFSA, Box 358, 420 Delaware Street SE, Minneapolis, MN 55455. To purchase multiple reprints call or fax a request to WB Saunders (tel: 215-238-5534; fax: 215-238-6423).

Heart Failure Society of America, Inc., Minneapolis, MinnesotaUSA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This document is available on the HFSA web site (www.hfsa.org).

PII: S1071-9164(99)91340-4

Journal of Cardiac Failure
Volume 5, Issue 4 , Pages 357-382, December 1999

Article Tools